Equity Overview
Price & Market Data
Price: $3.23
Daily Change: $0.00 / 0.00%
Daily Range: $2.62 - $3.32
Market Cap: $171,965,168
Daily Volume: 1,002,437
Performance Metrics
1 Week: 11.76%
1 Month: -29.48%
3 Months: -35.01%
6 Months: 4.19%
1 Year: 26.67%
YTD: -35.01%
Company Details
Employees: 28
Sector: Health technology
Industry: Pharmaceuticals: major
Country: Canada
Details
Achieve Life Sciences, Inc., a late-stage pharmaceutical company, develops and commercializes cytisinicline for nicotine independence in Canada, the United States, and the United Kingdom. The company offers cytisinicline, a plant-based alkaloid that interacts with nicotine receptors in the brain that reduce the severity of nicotine withdrawal symptoms. It has license and supply agreement with Sopharma AD and University of Bristol. Achieve Life Sciences, Inc., is headquartered in Bothell, Washington.